In-situ oxygen-generation nanoplatform with dual amplification effect for combined chemo-photodynamic therapy
Abstract Background Photodynamic therapy (PDT) is a promising method for cancer treatment because of its advantages such as easy operation, good targeting, minimal side effects, low systemic toxicity and less invasiveness. However, the hypoxic microenvironment within the tumor significantly inhibited the therapeutic effect of PDT. The development of targeted nanoplatform for regulating hypoxia microenvironment is an important method to give full play to the therapeutic effect of PDT. Methods In this study, we designed and prepared a novel chemo-photodynamic therapy nanoplatform, which can continuously catalyze the decomposition of H2O2 in tumors to generate oxygen (O2) to enhance the therapeutic effect of PDT, resulting in DNA damage, while releasing MTH1 inhibitors in tumor cells to inhibit the repair process of DNA damage caused by PDT. Results In our work, a simple one-step reduction approach was applied to enable platinum nanoparticles (Pt NPs) growth in situ in the nanochannels of mesoporous silica nanoparticles (MSNs). After physical encapsulation of photosensitizer chlorin e6 (Ce6) and MTH1 inhibitor TH588, the drug loading nanoplatform was modified with an arginine-glycine-aspartic acid (RGD) functionalized liposome shell, resulting in the fabrication of multifunctional nanoplatform MSN-Pt@Ce6/TH588@Liposome-RGD (MPCT@Li-R) with dual amplification effect and achieve the purpose of chemo-photodynamic therapy. Conclusions Our study provides a new strategy for PDT to ablation tumor cells by damaging the DNA of tumor nucleus and mitochondria, meanwhile inhibiting the repair process after the damage.